Search Details

Word: mid (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Harvard’s current solution to TF teaching (or the lack thereof)? As the Committee on Undergraduate Education reviewed last Wednesday, the College’s facile approach consists of optional mid-term TF evaluations and optional classes at the Derek Bok Center for Teaching and Learning. In the long-term, the preliminary report of the ongoing Harvard College Curricular Review suggests creating fellowships for outstanding TFs and making short training courses in evaluating student work mandatory for grad-student teachers. Dean of the Faculty of Arts and Sciences William C. Kirby also believes that instituting a system...

Author: By The Crimson Staff, | Title: Making Sections Work | 11/9/2004 | See Source »

Cusworth contributed 14 points and seven rebounds and Stehle added 21 and 11, respectively, as the two big men asserted themselves in the paint. The most impressive part of their performance had to be the execution of the high-low game, which appeared to be in mid-season form...

Author: By Michael R. James, CRIMSON STAFF WRITER | Title: Stehle, Cusworth Strong in Opening Scrimmage for M. Hoops | 11/8/2004 | See Source »

...choose to cut its dividend. So how can you tell if a particular dividend payer is a wise investment? Start by looking at dividend yield--the annual payout divided by the stock price. Still, betting on a company solely because it carries a high yield is risky. In mid-October, for instance, department-store company Saks offered a dividend yield above 16%. But the stock had fallen 33% over the previous six months, and uneven sales trends have dogged the company for the past two years. This may turn out to be a spectacular opportunity for investors--but it carries...

Author: /time Magazine | Title: Investing: High-Flying Dividends | 11/8/2004 | See Source »

Johnson & Johnson felt much the same way in the mid-1990s about its new business selling stents, the tiny devices used to prop open clogged arteries. With a virtual monopoly of the billion-dollar business, J&J alienated many of its cardiologist customers by charging high prices and failing to develop a new generation of product. When competitors like Guidant and Boston Scientific came out with their own stents, customers were eager to abandon J&J (which has admitted being slow to innovate but denies that its pricing was at fault). Says Sydney Finkelstein, a professor at Dartmouth's Tuck...

Author: /time Magazine | Title: Management: After The Flood | 11/8/2004 | See Source »

Though not the most egregiously underperforming defenseman, Welch struggled to do just that, most notably during the Crimson’s mid-year swoon...

Author: By Timothy J. Mcginn, CRIMSON STAFF WRITER | Title: Welch Seeks All-American End to College | 11/5/2004 | See Source »

Previous | 548 | 549 | 550 | 551 | 552 | 553 | 554 | 555 | 556 | 557 | 558 | 559 | 560 | 561 | 562 | 563 | 564 | 565 | 566 | 567 | 568 | Next